Skip to main content
Top
Published in: Current Neurology and Neuroscience Reports 12/2013

01-12-2013 | Neuro-Ophthalmology (A Kawasaki, Section Editor)

Posterior Cortical Atrophy: Review of the Recent Literature

Author: François-Xavier Borruat

Published in: Current Neurology and Neuroscience Reports | Issue 12/2013

Login to get access

Abstract

Posterior cortical atrophy (PCA) is a group of neurodegenerative dementing disorders characterized by initial predominant visual complaints followed by progressive decline in cognitive functions. The visuospatial and visuoperceptual defects arise from the dysfunction of, respectively, the dorsal (occipito-parietal) and the ventral (occipito-temporal) streams. Clinical symptoms, results of neuropsychological examination, and findings of posterior cerebral atrophy and/or posterior hypoperfusion/hypometabolism contribute to the diagnosis. However, owing to the insidious onset of PCA and the non-specificity of initial symptoms, the diagnosis is often delayed. Specific etiologies include Alzheimer’s disease, dementia with Lewy bodies, subcortical gliosis, corticobasal degeneration, and prion-associated diseases. Alzheimer’s disease accounts for at least 80 % of PCA cases. Recent research has concentrated on better defining the clinical presentation of PCA, improving neuroimaging analysis, testing new neuroimaging techniques, and developing biological measurements. Selected recent papers on PCA are reviewed in this article.
Literature
1.
2.
go back to reference Victoroff J, Ross GW, Benson DF, et al. Posterior cortical atrophy: neuropathologic correlations. Arch Neurol. 1994;51:269–74.PubMedCrossRef Victoroff J, Ross GW, Benson DF, et al. Posterior cortical atrophy: neuropathologic correlations. Arch Neurol. 1994;51:269–74.PubMedCrossRef
3.
go back to reference Tang-Wai DF, Graff-Radford NR, Boeve BF, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 2004;63:1168–74.PubMedCrossRef Tang-Wai DF, Graff-Radford NR, Boeve BF, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 2004;63:1168–74.PubMedCrossRef
4.
go back to reference Renner JA, Burns JM, Hou CE, et al. Progressive posterior cortical dysfunction. A clinicopathologic series. Neurology. 2004;63:1175–80.PubMedCrossRef Renner JA, Burns JM, Hou CE, et al. Progressive posterior cortical dysfunction. A clinicopathologic series. Neurology. 2004;63:1175–80.PubMedCrossRef
5.
go back to reference Mendez MF, Lee AS, Joshi A, Shapira JS. Nonamnestic presentations od early-onset Alzheimer’s disease. Am J Alzheimers Dis Other Dement. 2012;27:413–20.CrossRef Mendez MF, Lee AS, Joshi A, Shapira JS. Nonamnestic presentations od early-onset Alzheimer’s disease. Am J Alzheimers Dis Other Dement. 2012;27:413–20.CrossRef
6.
go back to reference Snowden JS, Stopford CL, Julien CL, et al. Cognitive phenotypes in Alzheimer’s disease and genetic risk. Cortex. 2007;43:835–45.PubMedCrossRef Snowden JS, Stopford CL, Julien CL, et al. Cognitive phenotypes in Alzheimer’s disease and genetic risk. Cortex. 2007;43:835–45.PubMedCrossRef
7.
go back to reference Untergleider LG, Haxby JV. “What” and “where” in the human brain. Curr Opin Neurol. 1994;4:157–65.CrossRef Untergleider LG, Haxby JV. “What” and “where” in the human brain. Curr Opin Neurol. 1994;4:157–65.CrossRef
8.
go back to reference • Crutch JS, Lehmann M, Schott JM, et al. Posterior cortical atrophy. Lancet Neurol. 2012;11:170–8. A very clear and concise review of PCA, written by world experts in the field of PCA.PubMedCrossRef • Crutch JS, Lehmann M, Schott JM, et al. Posterior cortical atrophy. Lancet Neurol. 2012;11:170–8. A very clear and concise review of PCA, written by world experts in the field of PCA.PubMedCrossRef
9.
go back to reference Crutch SJ, Schott JM, Rabinovici GD, et al. Shining a light on posterior cortical atrophy. Alzheimers Dement. 2013;9:463–5.PubMedCrossRef Crutch SJ, Schott JM, Rabinovici GD, et al. Shining a light on posterior cortical atrophy. Alzheimers Dement. 2013;9:463–5.PubMedCrossRef
10.
go back to reference Lee AG, Martin CO. Neuro-ophthalmic findings in the visual variant of Alzheimer’s disease. Ophthalmology. 2004;111:376–81.PubMedCrossRef Lee AG, Martin CO. Neuro-ophthalmic findings in the visual variant of Alzheimer’s disease. Ophthalmology. 2004;111:376–81.PubMedCrossRef
11.
go back to reference Formaglio M, Krolak-Salmon P, Tilikete C, et al. Homonymous hemianopia and posterior cortical atrophy. Rev Neurol. 2009;165:256–62.PubMedCrossRef Formaglio M, Krolak-Salmon P, Tilikete C, et al. Homonymous hemianopia and posterior cortical atrophy. Rev Neurol. 2009;165:256–62.PubMedCrossRef
12.
go back to reference Pelak VS, Smyth SF, Boyer PJ, Filley CM. Computerized visual field defects in posterior cortical atrophy. Neurology. 2011;77:2119–22.PubMedCrossRef Pelak VS, Smyth SF, Boyer PJ, Filley CM. Computerized visual field defects in posterior cortical atrophy. Neurology. 2011;77:2119–22.PubMedCrossRef
13.
go back to reference René R, Munoz S, Campdelacreu J, et al. Complex visual manifestations of posterior cortical atrophy. J Neuroophthalmol. 2012;32:307–12.PubMedCrossRef René R, Munoz S, Campdelacreu J, et al. Complex visual manifestations of posterior cortical atrophy. J Neuroophthalmol. 2012;32:307–12.PubMedCrossRef
14.
go back to reference Andrade K, Samri D, Sarazin M, et al. Visual neglect in posterior cortical atrophy. BMC Neurol. 2010;10:68.PubMedCrossRef Andrade K, Samri D, Sarazin M, et al. Visual neglect in posterior cortical atrophy. BMC Neurol. 2010;10:68.PubMedCrossRef
15.
go back to reference Andrade K, Kas A, Valabrègue R, et al. Visuospatial deficits in posterior cortical atrophy: structural and functional correlates. J Neurol Neurosurg Psychiatry. 2012;83:860–3.PubMedCrossRef Andrade K, Kas A, Valabrègue R, et al. Visuospatial deficits in posterior cortical atrophy: structural and functional correlates. J Neurol Neurosurg Psychiatry. 2012;83:860–3.PubMedCrossRef
16.
go back to reference • Andrade K, Kas A, Samri D, et al. Visuospatial deficits and hemispheric perfusion asymmetries in posterior cortical atrophy. Cortex. 2013;49:940–7. Case–control study of hemineglect and brain perfusion in a large group of PCA patients.PubMedCrossRef • Andrade K, Kas A, Samri D, et al. Visuospatial deficits and hemispheric perfusion asymmetries in posterior cortical atrophy. Cortex. 2013;49:940–7. Case–control study of hemineglect and brain perfusion in a large group of PCA patients.PubMedCrossRef
17.
go back to reference • Lehmann M, Barnes J, Ridgway GR, et al. Basic visual function and cortical thickness patterns in posterior cortical atrophy. Cereb Cortex. 2011;21:2122–32. This is one of the few studies which has addressed basic visual deficits in a large series of PCA patients. Regional cortical thickness analysis per se did not allow to separate patients with specific visuospatial from those with visuoperceptual disorders.PubMedCrossRef • Lehmann M, Barnes J, Ridgway GR, et al. Basic visual function and cortical thickness patterns in posterior cortical atrophy. Cereb Cortex. 2011;21:2122–32. This is one of the few studies which has addressed basic visual deficits in a large series of PCA patients. Regional cortical thickness analysis per se did not allow to separate patients with specific visuospatial from those with visuoperceptual disorders.PubMedCrossRef
18.
go back to reference • Kas A, Cruz de Souza L, Samri D, et al. Neural correlates of cognitive impairment in posterior cortical atrophy. Brain. 2011;134:1464–78. Large study correlating cognitive impairment and brain perfusion deficits by SPECT.PubMedCrossRef • Kas A, Cruz de Souza L, Samri D, et al. Neural correlates of cognitive impairment in posterior cortical atrophy. Brain. 2011;134:1464–78. Large study correlating cognitive impairment and brain perfusion deficits by SPECT.PubMedCrossRef
19.
go back to reference • Meek BP, Shelton P, Marotta JJ. Posterior cortical atrophy: visuomotor deficits in reaching and grasping. Front Hum Neurosci. 2013;7:1–16. First quantitative study of visuomotor deficits in PCA. • Meek BP, Shelton P, Marotta JJ. Posterior cortical atrophy: visuomotor deficits in reaching and grasping. Front Hum Neurosci. 2013;7:1–16. First quantitative study of visuomotor deficits in PCA.
20.
go back to reference Yong KXX, Warren JD, Warrington EK, Crutch SJ. Intact reading in patients with profound early visual dysfunction. Cortex. 2013 February 13 [Epub ahead of print]. Yong KXX, Warren JD, Warrington EK, Crutch SJ. Intact reading in patients with profound early visual dysfunction. Cortex. 2013 February 13 [Epub ahead of print].
21.
go back to reference Crutch SJ, Lehmann M, Gorgoraptis N, et al. Abnormal visual phenomena in posterior cortical atrophy. Neurocase. 2011;17:160–77.PubMedCrossRef Crutch SJ, Lehmann M, Gorgoraptis N, et al. Abnormal visual phenomena in posterior cortical atrophy. Neurocase. 2011;17:160–77.PubMedCrossRef
22.
go back to reference Sugimoto A, Midorikawa A, Koyama S, et al. Picture agnosia as a characteristic of posterior cortical atrophy. Eur Neurol. 2012;68:34–41.PubMedCrossRef Sugimoto A, Midorikawa A, Koyama S, et al. Picture agnosia as a characteristic of posterior cortical atrophy. Eur Neurol. 2012;68:34–41.PubMedCrossRef
23.
go back to reference Gardini S, Concari L, Pagliara S, et al. Visuo-spatial imagery impairment in posterior cortical atrophy: a cognitive and SPECT study. Behav Neurol. 2011;24:123–32.PubMed Gardini S, Concari L, Pagliara S, et al. Visuo-spatial imagery impairment in posterior cortical atrophy: a cognitive and SPECT study. Behav Neurol. 2011;24:123–32.PubMed
24.
go back to reference Magnin E, Sylvestre G, Lenoir F, et al. Logopenic syndrome in posterior cortical atrophy. J Neurol. 2013;260:528–33.PubMedCrossRef Magnin E, Sylvestre G, Lenoir F, et al. Logopenic syndrome in posterior cortical atrophy. J Neurol. 2013;260:528–33.PubMedCrossRef
25.
go back to reference Crutch SJ, Lehmann M, Warren DJ, Rohrer JD. The language profile of posterior cortical atrophy. J Neurol Neurosurg Psychiatry. 2013;84:460–6.PubMedCrossRef Crutch SJ, Lehmann M, Warren DJ, Rohrer JD. The language profile of posterior cortical atrophy. J Neurol Neurosurg Psychiatry. 2013;84:460–6.PubMedCrossRef
26.
go back to reference Witoonpanich P, Cash DM, Shakespare TJ, et al. Olfactory impairment in posterior cortical atrophy. J Neurol Neurosurg Psychiatry. 2013;84:588–90.PubMedCrossRef Witoonpanich P, Cash DM, Shakespare TJ, et al. Olfactory impairment in posterior cortical atrophy. J Neurol Neurosurg Psychiatry. 2013;84:588–90.PubMedCrossRef
27.
go back to reference Kennedy J, Lehmann M, Sokolska MJ, et al. Visualizing the emergence of posterior cortical atrophy. Neurocase. 2012;18:248–57. A case report describing the very early MRI deficits of PCA and its evolution over the years.PubMedCrossRef Kennedy J, Lehmann M, Sokolska MJ, et al. Visualizing the emergence of posterior cortical atrophy. Neurocase. 2012;18:248–57. A case report describing the very early MRI deficits of PCA and its evolution over the years.PubMedCrossRef
28.
go back to reference • Lehmann M, Barnes J, Ridgway GR, et al. Global grey matter changes in posterior cortical atrophy: a serial imaging study. Alzheimers Dement. 2012;8:502–12. This case–control MRI study demonstrated that PCA evolves from a focal to a global pattern of gray matter atrophy over time.PubMedCrossRef • Lehmann M, Barnes J, Ridgway GR, et al. Global grey matter changes in posterior cortical atrophy: a serial imaging study. Alzheimers Dement. 2012;8:502–12. This case–control MRI study demonstrated that PCA evolves from a focal to a global pattern of gray matter atrophy over time.PubMedCrossRef
29.
go back to reference Koedam ELGE, Lehmann M, van der Flier WM, et al. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol. 2011;21:2618–25.PubMedCrossRef Koedam ELGE, Lehmann M, van der Flier WM, et al. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol. 2011;21:2618–25.PubMedCrossRef
30.
go back to reference • Lehmann M, Koedam ELGE, Barnes J, et al. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer’s disease. Neurobiol Aging. 2012;33:627-e1–627.e12. This large MRI study questioned whether posterior atrophy was a marker of AD, and the authors found so. • Lehmann M, Koedam ELGE, Barnes J, et al. Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer’s disease. Neurobiol Aging. 2012;33:627-e1–627.e12. This large MRI study questioned whether posterior atrophy was a marker of AD, and the authors found so.
31.
go back to reference O’Donovan J, Watson R, Colloby S, et al. Does posterior cortical atrophy on MRI discriminate between Alzheimer’s disease, dementia with Lewy bodies, and normal aging? Int Psychogeriatr. 2013;25:111–9.PubMedCrossRef O’Donovan J, Watson R, Colloby S, et al. Does posterior cortical atrophy on MRI discriminate between Alzheimer’s disease, dementia with Lewy bodies, and normal aging? Int Psychogeriatr. 2013;25:111–9.PubMedCrossRef
32.
go back to reference • Ridgway GR, Lehmann M, Barnes J, et al. Early-onset Alzheiner disease clinical variants. Multivariate analyses of cortical thickness. Neurology. 2012;79:80–4. This large case–control MRI study demonstrated that the clinical variants of AD, including PCA, fall within the spectrum of the neuroanatomical defects of AD.PubMedCrossRef • Ridgway GR, Lehmann M, Barnes J, et al. Early-onset Alzheiner disease clinical variants. Multivariate analyses of cortical thickness. Neurology. 2012;79:80–4. This large case–control MRI study demonstrated that the clinical variants of AD, including PCA, fall within the spectrum of the neuroanatomical defects of AD.PubMedCrossRef
33.
go back to reference Alves J, Soares JM, Sampaio A, Goncalves OF. Posterior cortical atrophy and Alzheimer’s disease: a meta-analytic review of neuropsychological and brain morphometry studies. Brain Imaging Behav. 2013 May 21 [Epub ahead of print]. Alves J, Soares JM, Sampaio A, Goncalves OF. Posterior cortical atrophy and Alzheimer’s disease: a meta-analytic review of neuropsychological and brain morphometry studies. Brain Imaging Behav. 2013 May 21 [Epub ahead of print].
34.
go back to reference Migliaccio R, Agosta F, Toba MN, et al. Brain networks in posterior cortical atrophy: a single case tractography study and literature review. Cortex. 2012;48:1298–309.PubMedCrossRef Migliaccio R, Agosta F, Toba MN, et al. Brain networks in posterior cortical atrophy: a single case tractography study and literature review. Cortex. 2012;48:1298–309.PubMedCrossRef
35.
go back to reference • Migliaccio R, Agosta F, Scola E, et al. Ventral and dorsal visual streams in posterior cortical atrophy: a DT MRI study. Neurobiol Aging. 2012;33:2572–84. A case series study that investigated the topography of specific white matter tract lesions in PCA, and correlated it with clinical defects of either the dorsal or the ventral stream.PubMedCrossRef • Migliaccio R, Agosta F, Scola E, et al. Ventral and dorsal visual streams in posterior cortical atrophy: a DT MRI study. Neurobiol Aging. 2012;33:2572–84. A case series study that investigated the topography of specific white matter tract lesions in PCA, and correlated it with clinical defects of either the dorsal or the ventral stream.PubMedCrossRef
36.
go back to reference • Migliaccio R, Agosta F, Possin KL, et al. White matter atrophy in Alzheimer’s disease variants. Alzheimers Dement. 2012;8:S78–87. A large case-controlled MRI series investigated whether specific patterns of white matter atrophy were present in PCA and other variants of AD. Results support the hypothesis that cognitive deficits in PCA result from a neural network dysfunction involving both gray and white matter.PubMedCrossRef • Migliaccio R, Agosta F, Possin KL, et al. White matter atrophy in Alzheimer’s disease variants. Alzheimers Dement. 2012;8:S78–87. A large case-controlled MRI series investigated whether specific patterns of white matter atrophy were present in PCA and other variants of AD. Results support the hypothesis that cognitive deficits in PCA result from a neural network dysfunction involving both gray and white matter.PubMedCrossRef
37.
go back to reference Nestor PJ, Caine D, Fryer TD, et al. The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer’s disease) with FDG-PET. J Neurol Neurosurg Psychiatry. 2003;74:1521–9.PubMedCrossRef Nestor PJ, Caine D, Fryer TD, et al. The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer’s disease) with FDG-PET. J Neurol Neurosurg Psychiatry. 2003;74:1521–9.PubMedCrossRef
38.
go back to reference • Rosenbloom MH, Alkalay A, Agarwal N, et al. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology. 2011;6:1789–96. This case-controlled study investigated the relationship of amyloid deposits and clinical/metabolic defects in PCA and AD. Diffuse amyloid deposits were found in AD and PCA, and did not correlate with cortical dysfunction in PCA, whereas posterior glucose hypometabolism differentiated PCA from AD.CrossRef • Rosenbloom MH, Alkalay A, Agarwal N, et al. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology. 2011;6:1789–96. This case-controlled study investigated the relationship of amyloid deposits and clinical/metabolic defects in PCA and AD. Diffuse amyloid deposits were found in AD and PCA, and did not correlate with cortical dysfunction in PCA, whereas posterior glucose hypometabolism differentiated PCA from AD.CrossRef
39.
go back to reference Cruz de Sousa L, Corlier F, Habert MO, et al. Similar amyloid-β burden in posterior cortical atrophy and Alzheimer’s disease. Brain. 2011;134:2036–43.CrossRef Cruz de Sousa L, Corlier F, Habert MO, et al. Similar amyloid-β burden in posterior cortical atrophy and Alzheimer’s disease. Brain. 2011;134:2036–43.CrossRef
40.
go back to reference La Joie R, Perrotin A, Barré L, et al. Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer’s disease dementia. J Neurosci. 2012;32:16265–73.PubMedCrossRef La Joie R, Perrotin A, Barré L, et al. Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer’s disease dementia. J Neurosci. 2012;32:16265–73.PubMedCrossRef
41.
go back to reference Depaz R, Haik S, Peoc’h K, et al. Long-standing prion dementia manifesting as posterior cortical atrophy. Alzheimer Dis Assoc Disord. 2012;26:289–92.PubMedCrossRef Depaz R, Haik S, Peoc’h K, et al. Long-standing prion dementia manifesting as posterior cortical atrophy. Alzheimer Dis Assoc Disord. 2012;26:289–92.PubMedCrossRef
42.
go back to reference Jellinger KA, Grazer A, Petrovic K, et al. Four-repeat tauopathy clinically presenting as posterior cortical atrophy: atypical corticobasal degeneration? Acta Neuropathol. 2011;121:267–77.PubMedCrossRef Jellinger KA, Grazer A, Petrovic K, et al. Four-repeat tauopathy clinically presenting as posterior cortical atrophy: atypical corticobasal degeneration? Acta Neuropathol. 2011;121:267–77.PubMedCrossRef
43.
go back to reference Fragassi NA, Chiacchio L, Errichiello L, et al. Posterior cortical atrophy with prominent alexia without agraphia in a Tourette syndrome. Neurol Sci. 2011;32:1129–33.PubMedCrossRef Fragassi NA, Chiacchio L, Errichiello L, et al. Posterior cortical atrophy with prominent alexia without agraphia in a Tourette syndrome. Neurol Sci. 2011;32:1129–33.PubMedCrossRef
44.
go back to reference Sitek EJ, Narozanska E, Peplonska B, et al. A patient with posterior cortical atrophy possesse a novel mutation in the presenilin 1 gene. PLoS ONE. 2013;8:e61074.PubMedCrossRef Sitek EJ, Narozanska E, Peplonska B, et al. A patient with posterior cortical atrophy possesse a novel mutation in the presenilin 1 gene. PLoS ONE. 2013;8:e61074.PubMedCrossRef
45.
go back to reference • Seguin J, Formaglio M, Perret-Liaudet M, et al. CSF biomarkers in posterior cortical atrophy. Neurology. 2011;76:1782–8. Very useful results from this large prospective study of CSF profile of PCA versus AD.PubMedCrossRef • Seguin J, Formaglio M, Perret-Liaudet M, et al. CSF biomarkers in posterior cortical atrophy. Neurology. 2011;76:1782–8. Very useful results from this large prospective study of CSF profile of PCA versus AD.PubMedCrossRef
46.
go back to reference Cruz de Sousa L, Corlier F, Habert MO, et al. Similar amyloid-β burden in posterior cortical atrophy and Alzheimer’s disease. Brain. 2011;134:1036–43. Cruz de Sousa L, Corlier F, Habert MO, et al. Similar amyloid-β burden in posterior cortical atrophy and Alzheimer’s disease. Brain. 2011;134:1036–43.
47.
go back to reference Cruz de Sousa L, Lamari F, Belliard S, et al. Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer’s disease from other cortical dementias. J Neurol Neurosurg Psychiatry. 2011;82:240–6.CrossRef Cruz de Sousa L, Lamari F, Belliard S, et al. Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer’s disease from other cortical dementias. J Neurol Neurosurg Psychiatry. 2011;82:240–6.CrossRef
48.
go back to reference Beaufils E, Dufour-Rainfray D, Hommet C, et al. Confirmation of the amyloidogenic process in posterior cortical atrophy: value of the Aβ42/Aβ40 ratio. J Alzheimers Dis. 2013;33:775–80.PubMed Beaufils E, Dufour-Rainfray D, Hommet C, et al. Confirmation of the amyloidogenic process in posterior cortical atrophy: value of the Aβ42/Aβ40 ratio. J Alzheimers Dis. 2013;33:775–80.PubMed
49.
go back to reference • Dorothée G, Bottlaender M, Moukari E, et al. Distinct patterns of antiamyloid-β antibodies in typical and atypical Alzheimer disease. Arch Neurol. 2012;69:1181–5. Studying the patterns of antiamyloid-β antibodies might help a better categorization of patients suspected of PCA.PubMedCrossRef • Dorothée G, Bottlaender M, Moukari E, et al. Distinct patterns of antiamyloid-β antibodies in typical and atypical Alzheimer disease. Arch Neurol. 2012;69:1181–5. Studying the patterns of antiamyloid-β antibodies might help a better categorization of patients suspected of PCA.PubMedCrossRef
50.
go back to reference • Schneider LS. Alzheimer disease pharmacologic treatment and treatment research. Continuum (Minneap Minn). 2013;19:339–57. Although not directed specifically at PCA, this paper extensively reviewed both the actual and the future modalities to treat AD. • Schneider LS. Alzheimer disease pharmacologic treatment and treatment research. Continuum (Minneap Minn). 2013;19:339–57. Although not directed specifically at PCA, this paper extensively reviewed both the actual and the future modalities to treat AD.
51.
go back to reference McMonagle P. Posterior cortical atrophy and cholinesterase inhibitors: do they help? Neurology. 2010;74:A410. McMonagle P. Posterior cortical atrophy and cholinesterase inhibitors: do they help? Neurology. 2010;74:A410.
52.
go back to reference Videaud H, Torny F, Cartz-Piver L, et al. Impact of drug-free care in posterior cortical atrophy: preliminary experience with a psycho-educative program. Rev Neurol. 2012;168:861–7.PubMedCrossRef Videaud H, Torny F, Cartz-Piver L, et al. Impact of drug-free care in posterior cortical atrophy: preliminary experience with a psycho-educative program. Rev Neurol. 2012;168:861–7.PubMedCrossRef
53.
go back to reference Weill-Chounlamountry A, Poncet F, Crop S, et al. Physical medicine and rehabilitation multidisciplinary approach in a case of posterior cortical atrophy. Ann Phys Rehab Med. 2012;55:430–9.CrossRef Weill-Chounlamountry A, Poncet F, Crop S, et al. Physical medicine and rehabilitation multidisciplinary approach in a case of posterior cortical atrophy. Ann Phys Rehab Med. 2012;55:430–9.CrossRef
Metadata
Title
Posterior Cortical Atrophy: Review of the Recent Literature
Author
François-Xavier Borruat
Publication date
01-12-2013
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 12/2013
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-013-0406-8

Other articles of this Issue 12/2013

Current Neurology and Neuroscience Reports 12/2013 Go to the issue

Demyelinating Disorders (DN Bourdette and V Yadav, Section Editors)

Misdiagnosis of Multiple Sclerosis: Frequency, Causes, Effects, and Prevention

Movement Disorders (SA Factor, Section Editor)

Genetics in Dystonia: An Update

Neuro-Ophthalmology (A Kawasaki, Section Editor)

Neuro-ophthalmologic Complications of Neoplastic Leptomeningeal Disease

Movement Disorders (SA Factor, Section Editor)

Depression and Parkinson’s Disease: Current Knowledge